Mandates for Shared Decisions: Means to which Ends?
作者信息
Kramer Daniel B
出版信息
J Law Med Ethics. 2021;49(4):630-632. doi: 10.1017/jme.2021.86.
Abstract
摘要
相似文献
1
Mandates for Shared Decisions: Means to which Ends?共同决策的要求：手段服务于何种目的？
J Law Med Ethics. 2021;49(4):630-632. doi: 10.1017/jme.2021.86.
2
Putting the "Informed" in the informed consent process for implantable cardioverter-defibrillators: Addressing the needs of the elderly patient.在植入式心脏复律除颤器的知情同意过程中实现“充分知情”：满足老年患者的需求
Pacing Clin Electrophysiol. 2018 Mar;41(3):312-320. doi: 10.1111/pace.13288. Epub 2018 Feb 16.
3
Planning ahead: End-of-life decisions for patients with defibrillators.提前规划：植入除颤器患者的临终决策
Pacing Clin Electrophysiol. 2019 May;42(5):548-552. doi: 10.1111/pace.13641. Epub 2019 Apr 3.
4
Deactivating implantable cardioverter defibrillators.停用植入式心脏复律除颤器
Ann Intern Med. 2005 Nov 1;143(9):691; author reply 691. doi: 10.7326/0003-4819-143-9-200511010-00017.
5
The politics of information: informed consent in abortion and end-of-life decision making.信息政治学：堕胎与临终决策中的知情同意
Am J Law Med. 2013;39(1):7-61. doi: 10.1177/009885881303900101.
6
A typology of shared decision making, informed consent, and simple consent.共同决策、知情同意和简单同意的类型学
Ann Intern Med. 2004 Jan 6;140(1):54-9. doi: 10.7326/0003-4819-140-1-200401060-00012.
7
Shared Decision-Making for Implantable Cardioverter-Defibrillators: Policy Goals, Metrics, and Challenges.植入式心脏复律除颤器的共同决策：政策目标、指标和挑战。
J Law Med Ethics. 2021;49(4):622-629. doi: 10.1017/jme.2021.85.
8
Physicians' perceptions of shared decision-making for implantable cardioverter-defibrillators: Results of a physician survey.医生对植入式心脏复律除颤器共同决策的看法：一项医生调查的结果。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2420-2426. doi: 10.1111/jce.14178. Epub 2019 Sep 25.
9
Digging Deeper: Understanding Trajectories and Experiences of Shared Decision-Making for Primary Prevention ICD Implantation.深入探讨：理解初级预防 ICD 植入的共享决策轨迹和体验。
J Card Fail. 2022 Sep;28(9):1437-1444. doi: 10.1016/j.cardfail.2022.04.014. Epub 2022 May 10.
10
Patient consent and implantable cardioverter defibrillators: some palliative care implications.患者同意与植入式心脏复律除颤器：一些姑息治疗的影响。
Int J Palliat Nurs. 2006 Oct;12(10):470-5. doi: 10.12968/ijpn.2006.12.10.22119.
引用本文的文献
1
Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation.心脏转复除颤器植入前向患者提供信息的主要差距：前瞻性患者欧洲评估。
Europace. 2023 Mar 30;25(3):1144-1151. doi: 10.1093/europace/euac275.
2
[Local therapeutic procedure for blisters of the skin: a position paper of the Initiative Chronic Wounds (ICW)].[皮肤水疱的局部治疗方法：慢性伤口倡议组织（ICW）立场文件]
Dermatologie (Heidelb). 2022 Oct;73(10):795-800. doi: 10.1007/s00105-022-05013-5. Epub 2022 Jun 9.
本文引用的文献
1
Shared Decision-Making for Implantable Cardioverter-Defibrillators: Policy Goals, Metrics, and Challenges.植入式心脏复律除颤器的共同决策：政策目标、指标和挑战。
J Law Med Ethics. 2021;49(4):622-629. doi: 10.1017/jme.2021.85.
2
Informed consent and compulsory medical device registries: ethics and opportunities.知情同意与强制性医疗器械注册：伦理与机遇。
J Med Ethics. 2022 Feb;48(2):79-82. doi: 10.1136/medethics-2020-107031. Epub 2021 Feb 19.
3
A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data.一项针对接受植入式心脏复律除颤器患者的共享决策支持干预的多中心试验：DECIDE-ICD 的原理、设计、医疗保险变化和试点数据。
Am Heart J. 2020 Aug;226:161-173. doi: 10.1016/j.ahj.2020.04.010. Epub 2020 Apr 20.
4
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use.是时候震撼这个系统了：超越目前用于一级预防植入式心脏复律除颤器使用的范式。
J Am Heart Assoc. 2020 Mar 3;9(5):e015139. doi: 10.1161/JAHA.119.015139. Epub 2020 Feb 24.
5
Outcomes following implantable cardioverter-defibrillator generator replacement in adults: A systematic review.成人植入式心脏转复除颤器（ICD）除颤器更换后的结局：系统评价。
Heart Rhythm. 2020 Jun;17(6):1036-1042. doi: 10.1016/j.hrthm.2020.01.005. Epub 2020 Jan 10.
6
Harmonizing Standards and Incentives in Medical Device Regulation: Lessons Learned from the Parallel Review Pathway.协调医疗器械监管中的标准与激励措施：平行审查途径的经验教训
J Law Med Ethics. 2018 Dec;46(4):1034-1039. doi: 10.1177/1073110518822005.
7
Medicare Mandates for Shared Decision Making in Cardiovascular Device Placement.医疗保险对心血管设备植入中共同决策的要求。
Circ Cardiovasc Qual Outcomes. 2019 Jul;12(7):e004899. doi: 10.1161/CIRCOUTCOMES.119.004899. Epub 2019 Jul 3.
8
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.使用和不使用植入式心脏复律除颤器的心脏再同步治疗中的机构层面差异与临床结局
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004763. doi: 10.1161/CIRCOUTCOMES.118.004763.
9
Incorporating patients' preference diagnosis in implantable cardioverter defibrillator decision-making: a review of recent literature.将患者偏好诊断纳入植入式心脏复律除颤器决策：近期文献综述
Curr Opin Cardiol. 2018 Jan;33(1):42-49. doi: 10.1097/HCO.0000000000000464.
10
Coverage of Magnetic Resonance Imaging for Patients With Cardiac Devices: Improving the Coverage With Evidence Development Program.心脏植入设备患者的磁共振成像覆盖范围：通过证据开发计划提高覆盖范围
JAMA Cardiol. 2017 Jul 1;2(7):711-712. doi: 10.1001/jamacardio.2017.1674.
Zotero 插件